2016;47:1303-1311. DOI: 10.1161/ STROKEAHA.115.01216

[32] Tho-Calvi SC, Thompson D, Saunders D, Agrawal S, Basu A, Chitre M, Chow G, Gibbon F, Hart A, Tallur KK, Kirkham F, Kneen R, McCullagh H, Mewasingh L, Vassallo G, Vijayakumar K, Wraige E, Yeo TH, Ganesan V. Clinical features, course, and outcomes of a UK cohort of pediatric moyamoya. Neurology. 2018; 90 (9). DOI: https://doi.org/10.1212/ WNL.0000000000005026

[33] Cooper AN, Anderson V, Hearps S, Greenham M, Hunt RW, Mackay MT, Monagle P, Gordon AL. The Pediatric Stroke Outcome Measure. A predictor of outcome following arterial ischemic stroke. Neurology. 2018; 90 (5). DOI https://doi.org/10.1212/ WNL.0000000000004906

[34] Funaki T, Takahashi JC, Miyamoto S. Late Cerebrovascular Events and Social Outcome after Adolescence: Long-term Outcome of Pediatric Moyamoya Disease. Neurologia Medico-Chirurgica (Tokyo). 2018; 15;58(6):240-246. DOI: 10.2176/ nmc.ra.2018-0026.

[35] Appireddy R, Ranjan M, Durafourt BA, Riva-Cambrin J, Hader WJ, Adelson PD. Surgery for Moyamoya Disease in Children. J Child Neurol. 2019 Aug; 34(9):517-529. DOI: 10.1177/0883073819844854.

[36] Piao J, Wu W, Yang Z, Yu J. Research Progress of Moyamoya Disease in Children. International Journal of Medical Sciences. 2015; 12 (7): 566-575. DOI: 10.7150/ijms.11719

[37] Kim W, Lee EY, Park SE, Park EK. Kim JS, Kim DS, Shim KW. Neuropsychological impacts of indirect revascularization for pediatric moyamoya disease. Child's Nervous System. 2018; 34(6):1199-1206 DOI: 10.1007/s00381-018-3804-z

[38] Williams TS, Westmacott R, Dlamini N, Granite L, Dirks P, Askalan R, Macgregor D, Moharir M, Deveber G. Intellectual ability and executive function in pediatric moyamoya vasculopathy. Developmental Medicine & Child Neurology. 2012; 54(1):30-7. DOI: 10.1111/j.1469-8749.2011.04144.x.

[39] Gutiérrez-Martignon, M, Prieto-Corona, B, Bernal, J, Rodríguez-Camacho, M, Salvador, J, García, A, Velasco, E, Grijalva, I, Armejo L. Cognitive outcome of a pediatric stroke case: Moyamoya disease. Panamerican Journal of Neuropsychology. 2020; 14 (2): 71-82. DOI: 10.7714/CNPS/14.2.301

[40] Ball AJ, Steinberg GK, Elbers J. Quality of Life in Pediatric Moyamoya Disease. Pediatric Neurology. 2016; 63: 60-65. https://doi.org/10.1016/j. pediatrneurol.2016.06.012

[41] Gupta SK, Agarwal A, and Mohanty M. Moyamoya Disease: Assessment of Neurological and neuropsychological outcome Following Revascularization Procedures. Journal of Neurological Surgery Part B: Skull Base 2013; 74(S 01): A179. DOI: 10.1055/s-0033-1336302

[42] Nehra A, Kaur H. Moyamoya Disease: a ray of hope from a psychosocial perspective. Annals of Neurosciences. 2015; 22 (2): 121-124. DOI: 10.5214/ans.0972.7531.221212

[43] Cusin-Lamônica DA, da Costa Ribeiro C, Duarte Pinto Ferraz PM, Merighi Tabaquim ML. Moyamoya disease: impact on the performance of oral and written language. CoDAS. 2016; 28(5):661-665. DOI: 10.1590/2317-1782/20162016010.

[44] Kronenbourg A, van den Berg E, van Schooneveld MM, Braun KPJ, Dios L, van der Zwan A, Klijna CJM. Cognitive Functions in Children and Adults with Moyamoya Vasculopathy: *Neuropsychology of Moyamoya Disease DOI: http://dx.doi.org/10.5772/intechopen.96558*

A Systematic Review and Meta-Analysis. Journal of Stroke. 2018;20(3):332-341. https://doi.org/10.5853/jos.2018.01550

[45] Kazumata K, Tokairin K, Sugiyama T, Ito M, Uchino H, Osanai T, Kawabori M, Nakayama N, Houkin K. Association of cognitive function with cerebral blood flow in children with moyamoya disease. Journal of Neurosurgery. 2019; DOI link: https:// doi.org/10.3171/2019.7.PEDS19312

[46] Li J, Liu X, Zhang D, Zhang Y, Wang R, Yuan J and Zhao J. Cognitive Performance Profile in Pediatric Moyamoya Disease Patients and Its Relationship With Regional Cerebral Blood Perfusion. 2019. Frontiers in Neurology; 10:1308. DOI: 10.3389/ fneur.2019.01308

[47] Scott RM, Smith, ER. Moyamoya disease and moyamoya syndrome. The New England Journal of Medicine. 2009; 360(12), 1226-1236. DOI: 10.1056/NEJMra0804622.

[48] DeDios-Sterna S, Ventura LM. A pediatric case of NF1 and moyamoya syndrome: neuropsychological evaluation pre- and post-EDAS. Applied Neuropsychology (Child). 2019; DOI: 10.1080/21622965.2019.1665292

[49] Patra S, Patnaik A. Pediatric moyamoya disease presenting as attention deficit hyperactivity disorder: Time to pay attention. Indian Journla of Psychiatry. 2019;61(5):544-545. DOI: 10.4103/ psychiatry.IndianJPsychiatry\_403\_18.

[50] Bose R, Banerjee AD. Paediatric Moyamoya Disease and Tourette's Syndrome: An Unusual Association Responding Favourably to Direct and Indirect Cerebral Revascularisation Surgery. Pediatric Neurosurgery. 2019;54:436-440 https://doi. org/10.1159/000503114

[51] Noureldine MHA, Saikali, I, Nassif A., Chahinian R, Sweid A, Kikano R, Mawad M. Pediatric Moyamoya Presenting as a Subarachnoid Hemorrhage from a Ruptured Anterior Cerebral Artery Aneurysm. World Neurosurgery. 2020; 134: 123-127. https://doi.org/10.1016/j. wneu.2019.10.157

[52] Inoue K, Shimokawa S, Yoshioka F, Ogata A, Masuoka J, Abe T. A case of pediatric moyamoya disease with severe cerebral vasospasm and delayed cerebral infarction following an intraventricular hemorrhage. Childs Nervous System. 2020 Jul 14. DOI: 10.1007/ s00381-020-04769-2.

[53] Espert R, Gadea M, Aliño M, Oltra-Cucarella J, Perpiñá C. Enfermedad de moyamoya: aspectos clínicos, neurorradiológicos, neuropsicolológicos y genéticos. Revista de Neurología. 2018; 66 (S01): 57-64 DOI: 10.33588/ rn.66S01.2017526

[54] Castañeda MA, Peña CS, Cabillas MLL. Enfermedad de Moyamoya: Cefalea crónica y demencia progresiva asociadas a infartos cerebrales multiples. Revista de Neuropsiquiatría. 2019; 82(4):285-292. DOI: 10.20453/rnp.v82i4.3650

[55] Festa JR, Schwarz LR, Pliskin N, Cullum CM, Lacritz L, Charbel FT, et al. Neurocognitive dysfunction in adult MMD disease. Journal of Neurology. 2010; 257: 806-15. DOI: 10.1007/s00415-009-5424-8

[56] Araki Y, Takagi Y, Ueda K, Ubukata S, Ishida J, Funaki T, et al. Cognitive function of patients with adult moyamoya disease. Journal of stroke and cerebrovascular diseases. 2014; 23(7): 1789-1794 DOI: 10.1016/j. jstrokecerebrovasdis.2014.04.032.

[57] Karzmark P, Zeifert PD, Bell-Stephens TE, Steinberg GK, Dorfman LJ. Neurocognitive impairment in adults with MMD disease without stroke. Neurosurgery 2012; 70: 634-8. DOI: 10.1227/ NEU.0b013e3182320d1a.

[58] He S, Duan R, Liu Z, Yuan L, Li T, Tan C, Shao J, Qin S, Wang R. Characteristics of cognitive impairment in adult asymptomatic MMD disease. BMC Neurology. 2020; 20: 322. https:// doi.org/10.1186/s12883-020-01898-8

[59] Weinberg DG, Rahme RJ, Aoun SG, Batjer HH, Bendok BB. Moyamoya disease: functional and neurocognitive outcomes in the pediatric and adult populations. Neurosurgery Focus. 2011; 30: E21. DOI: 10.3171/2011.3.FOCUS1150

[60] Takagi Y, Miyamoto S, COSMO-Japan Study Group. Cognitive dysfunction survey of the Japanese patients with MMD disease (COSMO-JAPAN Study): study protocol. Neurologia Medico-Chirurgica (Tokyo) 2015; 55: 199-203. DOI: 10.2176/nmc. ra.2014-0326.

[61] Nakagawara J, Osato T, Kamiyama K, Honjo K, Sugio H, Fumoto K, et al. Diagnostic imaging of higher brain dysfunction in patients with adult MMD disease using statistical imaging analysis for [123I] iomazenil single-photon emission computed tomography. Neurologia Medico-Chirurgica (Tokyo) 2012; 52: 318-26. DOI: 10.2176/nmc.52.318

[62] Karzmark P, Zeifert PD, Tan S. Dorfman LJ, Bell-Stephens TE, Steinberg GK. Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery. 2008; 62:1048-1052 DOI:10.1227/01. neu.0000325866.29634.4c.

[63] Mogensen MA, Karzmark P, Zeifert PD, Rosenberg J, Marks M, Steinberg GK, Dorfman LJ. Neuroradiologic Correlates of Cognitive Impairment in Adult Moyamoya Disease. AJNR American Journal of

Neuroradiology. 2012; 33:721-25 DOI: https://doi.org/10.3174/ajnr.A2852

[64] Jefferson AL, Glosser G, Detre JA, Sinson G, Liebeskind DS. Neuropsychological and perfusion MR imaging correlates of revascularization in a case of moyamoya syndrome. American Journal of Neuroradiology. 2006; 27(1): 98-100. PMID: 16418365 PMCID: PMC2721464

[65] Coutinho, VT. Cognitive Improvement After Microsurgical Revascularization for the Treatment of Moyamoya Disease [thesis]. North Florida: UNF Graduate Theses and Dissertations. 505. 2014. https:// digitalcommons.unf.edu/etd/505

[66] Zeifert PD, Karzmark P, Bell-Stephens TE, Steinberg GK, Dorfman L. Neurocognitive performance after cerebral revascularization in adult moyamoya disease. Stroke. 2017; 48:1514-1517. DOI: 10.1161/ STROKEAHA.116.016028

[67] Yanagihara W, Chida K, Kobayashi M, Kubo Y, Yoshida K, Terasaki K, Ogasawara K. Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease. Journal of Neurosurgery. 2019; 131:1716-1724. DOI: https://doi. org/10.3171/2018.7.JNS18149

[68] Calviere, L., Loubiere, P., Planton, M. et al. Decreased frontal white-matter diffusion and improved cognitive flexibility after burr-hole surgery in moyamoya angiopathy. BMC Neurology. 2020. 20: 30 https://doi.org/10.1186/ s12883-020-1614-x

[69] Miyoshi K, Chida K, Kobayashi M, Kubo Y, Yoshida K, Terasaki K, Ogasawara K. Two-year clinical, cerebral hemodynamic, and cognitive outcomes of adult patients undergoing

*Neuropsychology of Moyamoya Disease DOI: http://dx.doi.org/10.5772/intechopen.96558*

medication alone for symptomatically ischemic moyamoya disease without cerebral misery perfusion: a prospective cohort study. Neurosurgery. 2019; 84 (6): 1233. DOI: 10.1093/neuros/nyy234.

[70] Su SH, Hai J, Zhang L, Yu F, Wu YF. Assessment of cognitive function in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization. European Journal of Neurology. 2013; 20: 1081- 1087. DOI: 10.1111/ene.12138.

[71] Perna R, McGee J. Case series of adults with Moyamoya-related stroke and rehabilitation outcomes. Biology and Medicine Case Report. 2017; 1(1):24-26. DOI: 10.35841/ biology-medicine.1.1.24-26

[72] Jia-Bin S, Xi SD, Zhou SY, Zhang X, Jiang SH, Xu B, Chen L, Lei Y, MD, Gao C, Gu YX. Microstructural damage pattern of vascular cognitive impairment: a comparison between moyamoya disease and cerebrovascular atherosclerotic disease. Neural Regeneration Research. 2019; 14 (5): 858-867. DOI:10.4103/1673-5374.249234.

[73] Indorewalla K, McArdle M, Tomlinson E, Piryatinsky I. Neuropsychological profile associated with MMD disease: A case report. NeuroRehabilitation. 2020; 46 (4): 603- 611 DOI: 10.3233/NRE-192903.

[74] Shi Z, Wen Y-J, Huang Z, Yu LB, Zhang D. Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes. Stroke & Vascular Neurology. 2020: 5; e000309. DOI:10.1136/ svn-2019-000309

[75] Su JB, Xi SD, Zhou SY, Zhang X, Jiang SH, Xu B, Chen L, Lei Y, Gao C, Gu YX. Microstructural damage pattern of vascular cognitive impairment: a comparison between moyamoya disease and cerebrovascular atherosclerotic

disease. Neural Regeneration Research. 2019;14(5):858-867. DOI: 10.4103/1673-5374.249234.

[76] McDade G. Symptomatic schizophrenia with moya-moya disease. Behavioral Neurology. 1991;4(1):25-8. DOI: 10.3233/BEN-1991-4103.

[77] Nagata T, Harada D, Aoki K, et al. Effectiveness of carbamazepine for benzodiazepine-resistant impulsive aggression in a patient with frontal infarctions. Psychiatry and Clinical Neuroscience. 2007; 61:695-697. DOI: 10.1111/j.1440-1819.2007.01737.x.

[78] Zalonis I, Christidi F, Kararizou E, Triantafyllou NI, Spengos K, Vassilopoulos D. Cognitive deficits presenting as psychiatric symptoms in a patient with moyamoya disease. Psychological Reports. 2010; 107, 3: 727-732. DOI: 10.2466/02.13.15.22. PR0.107.6.727-732.

[79] Hong JY, Na SJ, Shin JW, Kim HS, Kim WC, et al. Moyamoya disease presenting as transient amnesia with cortical blindness. Journal of Neurosonology and Neuroimaging. 2019; 11(2): 169-172. DOI: https://doi. org/10.31728/jnn.2019.00067

[80] Richards M, Grzenda A, Nelson E, Gitlin M. Psychiatric Comorbidity in Moyamoya Disease and Preliminary Guidelines For Treatment. American Journal of Psychiatry. 2019; 176:4. https://doi.org/10.1176/appi. ajp.2018.18040404
